Brought to you by 
Aegerion goes public on third try; nets $44mm
27 Apr 2012
Executive Summary
Aegerion Pharmaceuticals Inc. (cardiovascular and metabolic therapeutics) has netted just over $44mm through its initial public offering of 5mm common shares at $9.50 each, well below the $14-16 range the company had expected.
Deal Industry
- Biotechnology
- Pharmaceuticals
Deal Status
- Final
Deal Type
-
Financing
- IPO
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Aegerion goes public on third try; nets $44mm
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice